Concern about possible cardiovascular problems associated with Vioxx, however, soon arose.
By contrast, Vioxx made $2.5 billion for Merck last year.
Celebrex and Vioxx have become household names in recent years.
Vioxx was easier on the stomach than aspirin, but it cost more.
The last days of Vioxx began with FedEx deliveries on Sept. 14.
Yet Merck continued advertising.
(On Friday, Pfizer Inc. issued a warning that its Cox-2 drug Bextra may increase cardiovascular risk for some patients.)
``This morning Merck is announcing a voluntary worldwide withdrawal of Vioxx,'' Gilmartin began.
The FDA's own study of the Vioxx safety issue has become mired in controversy.
